Vuzix Corp. Stock
Vuzix Corp. Stock
Vuzix Corp. took a tumble today and lost -€0.255 (-6.500%).
For the coming years our community has positive and negative things to say abot the Vuzix Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Vuzix Corp. in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vuzix Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vuzix Corp. | -6.500% | -12.636% | 44.490% | 27.155% | 18.474% | -24.407% | -77.293% |
| Matthews International Corp. | 0.900% | -3.448% | -7.438% | 21.938% | -0.444% | -40.426% | -29.114% |
| USANA Health Sciences Inc. | 2.000% | -1.290% | -2.548% | -40.234% | -7.273% | -74.068% | -82.105% |
| Pola Orbis Holdings Inc. | 0.000% | 0.758% | -1.481% | -18.405% | -4.317% | -47.638% | -68.632% |
Comments
Vuzix (NASDAQ:VUZI) had its "buy" rating reaffirmed by analysts at Craig Hallum.
Show more
Ratings data for VUZI provided by MarketBeat
Vuzix Co. (NASDAQ: VUZI) had its price target lowered by analysts at Craig Hallum from $3.00 to $2.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VUZI provided by MarketBeat
Vuzix Co. (NASDAQ: VUZI) had its price target lowered by analysts at Craig Hallum from $3.50 to $3.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VUZI provided by MarketBeat
News
Why Vuzix Stock Sank Today
Amid pressures for tech valuations, Vuzix (NASDAQ: VUZI) stock ended Friday's trading in the red. The augmented-reality (AR) company's share price closed out the day down 2.6% and had been off as
Vuzix Q1 Earnings Call Highlights
Vuzix (NASDAQ:VUZI) reported a smaller first-quarter loss as operating expenses declined, while revenue fell year over year amid lower product sales
